Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Actuate Therapeutics Inc.
Hoffmann-La Roche
Mayo Clinic
Zhejiang Provincial People's Hospital
Hoffmann-La Roche
National Cancer Institute (NCI)